GlaxoSmithKline (GSK.L) has taken profits in Aspen Pharmacare (APNJ.J) by selling half its stake in the South African drugmaker for $853 million, following a long investment in the firm.
Aspen Pharmacare
Breaking News
Shareholders of Chile-based firm CFR Pharmaceuticals gave a nod on Friday for a sweetened takeover offer for South African drug maker Adcock Ingram in a bid to woo the top shareholder of the South African firm.
London-based pharmaceutical giant Glaxo SmithKline (GSK) completed the sale of its 28.2 million shares in Aspen Pharmacare at ZAR250 per share, raising a total of USD694 million in proceeds.
GSK had agreed to put its thromobosis drugs on sale to Aspen Pharmacare with proceeds to be used for general corporate purposes.
Subscribe to VCpost newsletter
Most Popular
- Doctors Raise Concerns Over Proposed Capital Gains Tax Changes
- How to Get IRS Unclaimed Tax Refunds: Here's What to Do If You Think You Have Pending Payments
- Tesla Shareholder Asks Judge to Prevent Elon Musk From Moving Pay Fight to Texas to Evade Delaware Ruling
- Walgreens to Open a New Pharmacy Offering Cell and Gene Therapies to Patients With Chronic Diseases Like Cancer
- Kroger and Albertsons to Sell off 166 Stores in Effort to Gain Approval for Their $25 Billion Merger
- Celebrity Designer Nancy Gonzalez Jailed for Smuggling Crocodile, Python Handbags
- How to Apply for Social Security Spousal Benefits; Here's How You May Boost Your Money!
- Illinois Woman, Who Mysteriously Drowned After Giving $1.5 Million to Online Romance Scammers, Knew She'd 'End up Dead'
